{
    "2021-02-03": [
        [
            {
                "time": "",
                "original_text": "上海家化(600315)：Q4净利润高增609% 大超预期 百亿收入未来可期",
                "features": {
                    "keywords": [
                        "上海家化",
                        "Q4",
                        "净利润",
                        "高增",
                        "609%",
                        "百亿收入"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "消费品",
                        "日化"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "上海家化(600315)：Q4盈利持续改善 业绩超预期",
                "features": {
                    "keywords": [
                        "上海家化",
                        "Q4",
                        "盈利",
                        "持续改善",
                        "业绩超预期"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "消费品",
                        "日化"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-02-03",
                "original_text": "片仔癀2月3日大宗交易成交3596.71万元",
                "features": {
                    "keywords": [
                        "片仔癀",
                        "大宗交易",
                        "成交",
                        "3596.71万元"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "中药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "医药生物2月月报：寻业绩主线 重点关CXO等高增长赛道",
                "features": {
                    "keywords": [
                        "医药生物",
                        "2月月报",
                        "业绩主线",
                        "CXO",
                        "高增长赛道"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}